Cistron Biotechnology(CIST)$.30 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (410)	2/15/1997 2:13:00 PM
From: Laertes Manuelidis	of 2742

Richard, I'm sure you're looking at 10Q which is now on public edgar. Peprotech settlement of ~$3mil (or any portion) is not on books yet. Sales were a bit disappointing year over year (also slow quarter as per your post) but CIST IMO will undoubtedly penetrate Il-1 and cytokine market over next 12 months. Additionally, anyone that wats to sell Il-1b from now on will have to pay royalties to CIST. If they don't, they will be subject to legal action. Lawyers for CIST, with case in hand, will be more than willing to oblige (BTW, did you see lawyers have 250,000 warrants to purchase CIST stock at $0.50 for next couple of years?). I didn't see any royalty income on the bal. sheet (other than R+D sys previous agreement). In the larger picture keep in mind that this $0.42 per share is basically CASH in hand. Based on current market value, valuation of CIST's patents, research agreements and collaborations is $0 (negative value?). I think not. Layman

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next